High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations

Our study adds evidence on the safety of low-to-moderate doses of ICS taken during the first trimester but raises concerns about high doses. However, we cannot rule out the possibility of residual confounding by severity in this association.